Omeprazole
امپرازول
🍽️ Alimentary Tract And MetabolismProton pump inhibitor
Market / country: 🇺🇸 USA
Prilosec (US)
🧮 Dose calculator
Gastroesophageal reflux disease · Regimen source: FDA Omeprazole · 2.2, Table 2FDA Omeprazole · 8.4
- • 10 to <20 kg: 10 mg; ≥20 kg: 20 mg; once daily before meals. A 20 mg capsule cannot give 10 mg. FDA Omeprazole · 2.2, Table 2FDA Omeprazole · 2.3
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to the formulation or substituted benzimidazoles; rilpivirine-containing products. FDA Omeprazole · 4
Formulations
- 20 mg delayed-release capsule — capsule 🇺🇸 USA FDA Omeprazole · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Omeprazole · 8.1
“Risk Summary There are no adequate and well-controlled studies with omeprazole in pregnant women.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Omeprazole · 8.2
“Risk Summary Limited data suggest omeprazole may be present in human milk.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Omeprazole · 8.4
“The safety and effectiveness of omeprazole have been established in pediatric patients 2 to 16 years for the treatment of symptomatic GERD, treatment of EE due to acid-mediated GERD, and maintenance of healing of EE due to acid-mediated GERD.”
- 👴 Older adultsNo specific problem stated
Label: no specific difference or dose adjustment stated for older adults. FDA Omeprazole · 8.5
“However, no dosage adjustment is necessary in the elderly [see Clinical Pharmacology (12.3) ].”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA078490
- DailyMed (FDA label)FDA Omeprazole
- MedlinePlus (NIH)Omeprazole
- WHO ATC/DDDA02BC01
- Darooyab (Iran)Omeprazole
🇮🇷 Registered in Iran Darooyab · G-2621/Omeprazole
Dosage forms with Iranian generic codes, per Darooyab.
- 00931 · OMEPRAZOLE 20MG CAP · کپسول امپرازول ۲۰ میلیگرم
- 07660 · OMEPRAZOLE 40MG CAP · کپسول امپرازول ۴۰ میلیگرم
- 51518 · OMEPRAZOLE POWDER, FOR SUSPENSION ORAL 20 mg · سوسپانسیون خوراکی امپرازول ۲۰ میلیگرم
- 52204 · OMEPRAZOLE (AS SODIUM) INJECTION, POWDER, FOR SOLUTION PARENTERAL 40 mg · پودر برای تهیه محلول تزریقی امپرازول (معادل سدیم) ۴۰ میلیگرم
- 53120 · OMEPRAZOLE / SODIUM BICARBONATE POWDER, FOR SUSPENSION ORAL 20 mg/1680 mg · سوسپانسیون خوراکی امپرازول / سدیم بیکربنات ۲۰ میلیگرم / ۱۶۸۰ میلیگرم
- 53121 · OMEPRAZOLE / SODIUM BICARBONATE POWDER, FOR SUSPENSION ORAL 40 mg/1680 mg · سوسپانسیون خوراکی امپرازول / سدیم بیکربنات ۴۰ میلیگرم / ۱۶۸۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Omeprazole · 3FDA Omeprazole · 2.2, Table 2FDA Omeprazole · 8.4FDA Omeprazole · 2.3FDA Omeprazole · 2.1, Table 1FDA Omeprazole · 4FDA Omeprazole · 8.1FDA Omeprazole · 8.2FDA Omeprazole · 8.5FDA Omeprazole · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-2621/Omeprazole
- Clinical review⚠ Unverified